Concepedia

Stacie S. Canan Koch

SS

8

Publications

621

Citations

8

H-Index

1989

Active since

Affiliations

Ligand Pharmaceuticals (United States)(Current)

Stacie S. Canan Koch is an author at Ligand Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesBiochemistryChemical BiologyMedicinal ChemistrySignal TransductionChemistryEngineering

Publications per year

1989–2005

8

Publications

8

Activation of specific RXR heterodimers by an antagonist of RXR homodimers

Deepak S. Lala, Ranjan Mukherjee, Ira G. Schulman et al. · Nature · 1996 · 164 citations

Molecular Pharmacology, Signal Transduction, Molecular Regulation +9

Novel Tricyclic Poly(ADP-ribose) Polymerase-1 Inhibitors with Potent Anticancer Chemopotentiating Activity: Design, Synthesis, and X-ray Cocrystal Structure

Stacie S. Canan Koch, Lars Thoresen, Jayashree Tikhe et al. · Journal of Medicinal Chemistry · 2002 · 134 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Parp-1 Protein +18

Enantioselective preparation of .beta.-alkyl-.gamma.-butyrolactones from functionalized ketene dithioacetals

Stacie S. Canan Koch, A. Richard Chamberlin · The Journal of Organic Chemistry · 1993 · 116 citations

Engineering, Enantioselective Preparation, Donut Icon +13

Modified Conditions for Efficient Baeyer-Villiger Oxidation with m-CPBA

Stacie S. Canan Koch, A. Richard Chamberlin · Synthetic Communications · 1989 · 61 citations

Advanced Oxidation Process, Chemical Engineering, 3-Chloroperoxybenzoic Acid +13

Synthesis of Retinoid X Receptor-Specific Ligands That Are Potent Inducers of Adipogenesis in 3T3-L1 Cells

Stacie S. Canan Koch, Laura J. Dardashti, Rosemary M. Cesario et al. · Journal of Medicinal Chemistry · 1999 · 59 citations · Full text

Redox Biology, Oxidative Stress, Medicinal Chemistry +19

Rows per page

1–5 of 8